Thursday, May 14, 1-2 p.m. ET
SAMHSA’s Center for Financing Reform and Innovation (CFRI) is releasing a report and hosting a webinar titled Revised Regulations for Opioid Treatment Programs: Establishing a Baseline to Measure Progress Over Time.
In 2024, revisions were made to 42 CFR part 8, the federal regulations that guide opioid treatment programs (OTPs). The revisions promote increased access to evidence-based medications for opioid use disorder (MOUD), greater retention in care by promoting practitioner’s professional judgment in providing a patient-centered approach to care and reducing barriers to receiving services.
Learn more about this report during SAMHSA’s webinar which examines the extent to which states/territories and OTPs have adopted the changes outlined in 42 CFR part 8 within the first year since the revised regulations were put into effect.
Speakers include:
- Karran Phillips, M.D., MSc, Acting Director, Center for Substance Abuse Treatment (CSAT), SAMHSA – Opening Remarks
- Jennifer Caputo, Ph.D., Senior Research Associate, Westat – Welcome/Housekeeping
- Rikki Welch, M.A., Principal Research Associate, Westat – Report Overview
- Nichole Smith, MHSA, Chief, Regulatory Programs Branch, Division of Pharmacologic Therapies (DPT), CSAT, SAMHSA – Panel Moderator
- Patti Juliana, Ph.D., LCSW, Division Director, DPT, CSAT, SAMHSA – Panelist
- Adam Bucon, LSW, State Opioid Treatment Authority, New Jersey Department of Human Services, Division of Mental Health and Addiction Services – Panelist (Invited)
- Chrissie Martin, LMFT, LAC-S, CS, National Clinical Director – Midwest Division, Behavioral Health Group™ – Panelist
- Dustin Mets, J.D., Chief Executive Officer, CompDrug – Panelist